December 11, 2017 8:03 PM ET

Pharmaceuticals

Company Overview of Calliditas Therapeutics AB

Key Executives for Calliditas Therapeutics AB

NameBoard RelationshipsTitleAge
Renee Aguiar-Lucander 31 RelationshipsChief Executive Officer55
Mikael Bender MBANo RelationshipsCo-Founder--
Fredrik Johansson No RelationshipsChief Financial Officer--
Johan Häggblad Ph.D.No RelationshipsChief Operating Officer--

Calliditas Therapeutics AB Board Members*

NameBoard RelationshipsPrimary CompanyAge
Thomas Lennart Eklund MBA 65 RelationshipsInvestor Growth Capital50
Hilde Furberg MSc 36 RelationshipsBerGenBio ASA59
Lennart Hansson Ph.D.(Genetics) 38 RelationshipsIndustrifonden61
Ann-Tove Kongsnes MSc 9 RelationshipsInvestinor AS50
Olav Hellebø MBA, BBA 24 RelationshipsReNeuron Group plc52
View All Board Members

Calliditas Therapeutics AB Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
379.3K
Bonus
402.7K
Total Short Term Compensation
524.2K
Total Value of Options
7.6M
Compensation as of Fiscal Year
Calliditas Therapeutics AB CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Paul Fonteyne Joins as an Independent Director of resTORbio, Inc
December 11, 2017 7:00 AM ET
Akari Therapeutics, Inc. Terminates Robert Shaw as Chief Legal & Compliance Officer and Company Secretary
December 08, 2017 9:30 PM ET
Aspen Pharmacare Holdings Limited Announces Appointments of Members to the Audit & Risk Committee
December 08, 2017 11:30 AM ET
Lyka Labs Limited Announces Resignation of Vinod Shanbhag as Independent Director
December 08, 2017 11:18 AM ET
Sihuan Pharmaceutical Holdings Group Ltd. Announces Management Changes
December 08, 2017 9:06 AM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Calliditas Therapeutics AB, please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.